In addition, repression of NF-κB target genes, e.g., CD44 and possibly other genes (e.g., BCL-XL, cMyc, and MMP9), decreased proliferation (Fig. 4) and invasiveness (Fig. 5) of breast cancer cells. Here, CD44 is linked to breast cancer.